Verastem (VSTM) PT Lowered to $3 at H.C. Wainwright
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts VSTM Hot Sheet
Price: $8.00 -3.26%
Rating Summary:
17 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 18 | New: 39
Rating Summary:
17 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 18 | New: 39
Join SI Premium – FREE
H.C. Wainwright analyst Swayampakula Ramakanth lowered the price target on Verastem (NASDAQ: VSTM) to $3.00 (from $5.00) while maintaining a Buy rating.
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on Verastem (VSTM)
- Haemonetics (HAE) PT Raised to $130 at BTIG
- Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
